Evidence map›Paper›PMID 30221455›Full record

ArticleThoracic cancer2018

Chinese multidisciplinary expert consensus: Guidelines on percutaneous transthoracic needle biopsy.

Zhi Guo, Hong Shi, Wentao Li, Dongmei Lin, Changli Wang, Chen Liu, Min Yuan, Xia Wu, Bin Xiong, Xinhong He and 24 more

Open access · goldAbstract readConsensus Statement
In one paragraph

Article in Thoracic cancer, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Observational
  14. Article
  15. Article
  16. Article
  17. Article
  18. CT-guided transthoracic core needle biopsies of focal pleural lesions smaller than 10 mm: a retrospective study.Cancer imaging : the official publication of the International Cancer Imaging Society · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors at 18 institutions in 1 country.

Zhi GuoDepartment of Interventional Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Hong ShiChinese Medical Association Publishing House, Beijing, China.
Wentao LiDepartment of Interventional Radiology, Fudan University Shanghai Cancer Center, Shanghai, China.
Dongmei LinDepartment of Pathology, Peking University Cancer Hospital, Beijing, China.
Changli WangDepartment of Interventional Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Chen LiuDepartment of Pathology, Peking University Cancer Hospital, Beijing, China.
Min YuanDepartment of Interventional Radiology, Shanghai Public Health Clinical Center, Shanghai, China.
Xia WuDepartment of Interventional Radiology, Sir Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Bin XiongDepartment of Interventional Radiology, Huazhong University of Science and Technology Affiliated with Union Hospital of Tongji Medical College, Wuhan, China.
Xinhong HeDepartment of Interventional Radiology, Fudan University Shanghai Cancer Center, Shanghai, China.
Feng DuanDepartment of Interventional Therapy, The General Hospital of People's Liberation Army, Beijing, China.
Jianjun HanDepartment of Interventional Therapy, Shandong Cancer Hospital, Jinan, China.
Xueling YangDepartment of Interventional Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.ORCID 0000-0001-5440-5351
Haipeng YuDepartment of Interventional Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Tongguo SiDepartment of Interventional Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Linfeng XuDepartment of Interventional Therapy, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
Wenge XingDepartment of Interventional Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Huang JinhuaDepartment of Interventional Therapy, Sun Yat-Sen University Cancer Center, Guangzhou, China.
Yingjuan WangDepartment of Interventional Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Hui XieDepartment of Interventional Therapy, 302 Military Hospital of China, Beijing, China.
Li CuiDepartment of Interventional Therapy, The General Hospital of People's Liberation Army, Beijing, China.
Wei GaoDepartment of Interventional Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Dongfeng HeThe Affiliated Cancer Hospital of Harbin Medical University, Harbin, China.
Changfu LiuDepartment of Interventional Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Zhou LiuDepartment of Interventional Therapy, Shenzhen Cancer Hospital, Shenzhen, China.
Chunhua MaDepartment of Interventional Therapy, Tianjin Huanhu Hospital, Tianjin, China.
Jie PanDepartment of Interventional Therapy, Peking Union Medical College Hospital, Beijing, China.
Haibo ShaoDepartment of Interventional Therapy, The First Affiliated Hospital of China Medical University, Shenyang, China.
Qiang TuDepartment of Interventional Therapy, Jiangxi Cancer Hospital, Nanchang, China.
Li YongDepartment of Interventional Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Yan XuDepartment of Interventional Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Zhang WeihaoDepartment of Interventional Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Zou QiangDepartment of Interventional Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Sen WangDepartment of Interventional Therapy, Tianjin Third Central Hospital, Tianjin, China.
Tianjin Medical University Cancer Institute and Hospital · CNPeking University · CNFudan University Shanghai Cancer Center · CNPeople's Liberation Army No. 150 Hospital · CNSun Yat-sen University · CN302 Military Hospital of China · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNChinese Medical Association · CNFirst Hospital of China Medical University · CNHarbin Medical University · CNJiangxi Provincial Cancer Hospital · CNShandong Tumor Hospital · CNShanghai Public Health Clinical Center · CNSir Run Run Shaw Hospital · CNTianjin Huanhu Hospital · CNTianjin Third Central Hospital · CNUnion Hospital · CNUniversity of Hong Kong - Shenzhen Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biopsy has been used to diagnose thoracic diseases for more than a century. Percutaneous needle biopsy plays a crucial role in the diagnosis, staging, and treatment planning for tumors in the lungs, thoracic wall, hilum, and mediastinum. With the continuous improvement in imaging techniques, the range of clinical applications for percutaneous needle biopsy is also expanding. It has become important to improve Chinese professionals' and technicians' understanding of percutaneous transthoracic needle biopsy (PTNB) in order to standardize operating procedures and to strengthen perioperative management. However, there is currently no Chinese expert consensus that provides systematic standardization and guidance for PTNB in clinical practice. The Committee of Chinese Society of Interventional Oncology (CSIO) of the Chinese Anti-Cancer Association (CACA) initiated a Chinese multidisciplinary expert consensus on PTNB. The consensus includes image-guided methods, indications, contraindications, multidisciplinary team recommendations, biopsy procedures, daytime/outpatient biopsy, complications, pathological examination, and management of negative results.

Indexed as

ConsensusBiopsy, NeedleChinaFemaleGuidelines as TopicHumansImage-Guided BiopsyMaleConsensusguidelinepercutaneous biopsytransthoracic cancer

Identifiers

PMID30221455
PMCPMC6209790
OpenAlexW2889667461

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.